A New Method Simplifies Blood Biomarker Discovery And Analysis Tuesday, August 16, 2016 Scientists at Karolinska Institutet in collaboration with Estonian Competence Centre on Health Technologies have developed a new gene expression analysis method to widen the usage of blood in biomarker discovery and analysis. Protagen, Inova Announce Agreement for BICD2 Biomarker Friday, August 12, 2016 The license agreement will allow Inova to add the novel biomarker to their portfolio of CTD reagents to help improve diagnosis of this debilitating disease.The Genetics Behind Anxiety Disorders Friday, August 12, 2016 Anxiety disorders are the most common type of mental illness in the United States. And while much is understood about the biochemistry of anxiety, little is known about the genetic variation associated with it.Metabolon Closes $15M Financing Round Friday, August 12, 2016 Metabolon has announced that it has closed a financing that raised $15 million from new investor Essex Woodlands, a leading healthcare growth equity firm. How Cloud Connectivity Can Combat the Reproducibility Crisis Friday, August 12, 2016 This infographic explains the reproducibility crisis, and how cloud connectivity can help overcome this problem.Gilead, Polyphor Partner to Discover Macrocycle Drugs Thursday, August 11, 2016 Polyphor Ltd has announced the signing of a collaboration and license agreement with Gilead Sciences Inc., Foster City, California, USA. Using Big Data to Discover Potential Cancer Biomarkers Thursday, August 11, 2016 University of Hawai'i Cancer Center researchers used "Big Data" to discover potential cancer biomarkers, a panel of six long intergenic non-coding RNAs (lincRNAs), for the diagnosis of all types of cancers including lung, breast, prostate, liver and ovarian cancers.Illumina, FlowJo Partner Thursday, August 11, 2016 Companies to develop software for analysis and reporting of single cell data will advance research into cell function, disease progression, and therapeutic response.Discovery of Key Component of HIV Yields New Drug Target Thursday, August 11, 2016 Scientists from the MRC Laboratory of Molecular Biology in Cambridge and University College London have discovered an essential feature of HIV that the virus uses to infect cells whilst avoiding detection by the immune system. This discovery presents a new drug target and the opportunity to re-evaluate existing treatments for HIV to improve their efficacy.